Free Trial

Kooth (KOO) Competitors

Kooth logo
GBX 151 -0.50 (-0.33%)
As of 11:24 AM Eastern

KOO vs. INS, RENX, COG, INHC, FDBK, IQAI, DVRG, TRLS, SENS, and EMIS

Should you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry.

Kooth vs. Its Competitors

Instem (LON:INS) and Kooth (LON:KOO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

Kooth has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Instem£61.63M0.00£3.34M£0.14N/A
Kooth£66.74M0.81£4.00M£0.21719.05

65.9% of Instem shares are owned by institutional investors. Comparatively, 28.3% of Kooth shares are owned by institutional investors. 30.0% of Instem shares are owned by insiders. Comparatively, 30.8% of Kooth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 18.59% beat Instem's return on equity.

Company Net Margins Return on Equity Return on Assets
Instem5.50% 6.35% 4.62%
Kooth 7.89%18.59%10.12%

Kooth has a consensus price target of GBX 395, suggesting a potential upside of 161.59%. Given Kooth's stronger consensus rating and higher probable upside, analysts plainly believe Kooth is more favorable than Instem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Instem
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Instem has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500. Comparatively, Kooth has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.

In the previous week, Kooth's average media sentiment score of 0.75 beat Instem's score of 0.00 indicating that Kooth is being referred to more favorably in the news media.

Company Overall Sentiment
Instem Neutral
Kooth Positive

Summary

Kooth beats Instem on 12 of the 14 factors compared between the two stocks.

Get Kooth News Delivered to You Automatically

Sign up to receive the latest news and ratings for KOO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KOO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KOO vs. The Competition

MetricKoothHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£54.56M£349.85M£5.79B£2.60B
Dividend YieldN/A5.89%5.63%5.31%
P/E Ratio719.05523.1476.485,395.57
Price / Sales0.81251.21531.9597,513.31
Price / Cash5.4247.1437.9227.93
Price / Book2.345.1413.729.20
Net Income£4.00M-£15.55M£3.29B£5.89B
7 Day Performance-1.31%6.86%1.03%0.74%
1 Month Performance-4.43%4.49%6.32%3.37%
1 Year Performance-56.26%14.46%81.16%190.45%

Kooth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KOO
Kooth
1.8085 of 5 stars
GBX 151
-0.3%
GBX 395
+161.6%
-55.7%£54.56M£66.74M719.05478
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
RENX
Renalytix
N/AGBX 6
+2.6%
N/A-15.0%£19.87M£2.37M-37.50102Gap Up
COG
Cambridge Cognition
N/AGBX 37.40
+6.9%
N/A-2.4%£17.19M£9.05M-984.2180News Coverage
Gap Up
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A+30.0%£9.00M£12.57M-1.7674
FDBK
Feedback
N/AGBX 13.30
+0.4%
N/A-75.8%£5.83M£1.19M-54.4224News Coverage
Earnings Report
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-38.5%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.58
+15.0%
N/A-46.1%£929K£114K-11.5031Gap Up
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560

Related Companies and Tools


This page (LON:KOO) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners